Veljovich, D. S., Rothe, M., Mangat, P. K., Garrett-Mayer, E., Ali-Ahmad, H. M., Naumann, R. W., Siedel, J., Chan, J. K., Gregory, A., Pisick, E. P., Adesunloye, B., Arend, R. C., Bell, M. C., Frimer, M., Tawfik, B., Thota, R., Tsimberidou, A. M., Gregory, A., Halabi, S., Schilsky, R. L. (2025). Palbociclib in patients (pts) with ovarian cancer (OC) with CDKN2A alterations: Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e17660